BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: D’amico F, Pugliese N, Peyrin-biroulet L, Danese S. Efficacy of anti-TNFα drugs in patients with stricturing Crohn’s disease. Expert Review of Gastroenterology & Hepatology 2020;14:347-53. [DOI: 10.1080/17474124.2020.1759417] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Lin XX, Qiu Y, Zhuang XJ, Liu F, Wu XM, Chen MH, Mao R. Intestinal stricture in Crohn's disease: A 2020 update. J Dig Dis 2021;22:390-8. [PMID: 34014617 DOI: 10.1111/1751-2980.13022] [Reference Citation Analysis]
2 Murate K, Nakamura M, Yamamura T, Maeda K, Sawada T, Mizutani Y, Ishikawa E, Kakushima N, Furukawa K, Ohno E, Honda T, Kawashima H, Ishigami M, Fujishiro M. Ustekinumab is effective against small bowel lesions in Crohn’s disease: two case reports. Clin J Gastroenterol 2021;14:129-35. [DOI: 10.1007/s12328-020-01242-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Shieh J, Kobayashi S, Yang VW. Aberrant differentiation of intestinal stem cells due to inflammation-induced mitochondrial dysfunction predicts postoperative recurrence of Crohn's disease. Dig Med Res 2020;3:98. [PMID: 33447825 DOI: 10.21037/dmr-2020-15] [Reference Citation Analysis]
4 Chen BX, Han ZM, Zhou Q, Liu HB, Xu PC, Zhi FC. Efficacy of infliximab in treatment-naïve patients with stricturing small bowel Crohn's disease. Scand J Gastroenterol 2021;56:812-9. [PMID: 33962533 DOI: 10.1080/00365521.2021.1922748] [Reference Citation Analysis]